Renaissance Capital logo

NYXH News

US IPO Weekly Recap: DiDi leads a 19 IPO week, the busiest since 2004

DIDI

In the US IPO market’s busiest week since 2004, 19 IPOs raised nearly $10 billion, led by Chinese ride-hailing giant DiDi Global (DIDI). The second largest IPO of the year, DiDi (DIDI) upsized and priced at the high end to raise $4.4 billion at a $70.4 billion market cap. DiDi is China’s dominant ride-hailing app, with 15...read more

Sleep apnea device maker Nyxoah prices US IPO at $30

NYXH

Nyxoah, which is commercializing a nerve stimulator implant for obstructive sleep apnea, raised $85 million by offering 2.8 million shares at $30, roughly in line with the as-converted last close of its shares on the Euronext Brussels (NYXH). Existing shareholders Cochlear Investments and ResMed had indicated an interest in buying up to $34 million of the IPO (40% of the deal). At...read more

US IPO Week Ahead: DiDi makes its billion-dollar debut in a 17 IPO week

DIDI

17 IPOs are slated to raise $9.1 billion in the week ahead, led by long-awaited Chinese ride-hailing giant DiDi Global (DIDI). DiDi (DIDI) plans to raise $3.9 billion at a $67.5 billion market cap. DiDi is China’s dominant ride-hailing app, with 15 million drivers across 4,000 cities and towns. The unprofitable company saw revenue...read more

Belgian sleep apnea device provider Nyxoah sets terms for $87 million US IPO

NYXH

Nyxoah, which is commercializing a nerve stimulator implant for obstructive sleep apnea, announced terms for its IPO on Friday. The Mont-Saint-Guibert, Belgium-based company plans to raise $87 million by offering 2.8 million shares at $31.46, above the as-converted last close of its shares on the Euronext Brussels (NYXH; $30.88). Insiders intend to purchase $34 million worth of...read more